Login | Register

Stivarga (Rcoloegorafenib) Approved For Colorectal Cancer Treatment

Stivarga (regorafenib), a multi-kinase inhibitor, has been approved for the treatment of metastatic colorectal cancer that has continued to spread after treatment, the FDA (Food and Drug Administration) informed today. The medication is presented as tablets and taken orally. Stivarga is a compound which was developed by Bayer Health Care and still belongs to the company...

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *